Summer Street Starts NUVA, ANIK, TRNX, TSON, BMTI, ATEC at Buy, MAKO at Neutral
Tweet
Share
E-mailGet Alerts NUVA Hot Sheet
Price: $39.75 --0%
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
In the Biotech and Drugs sector Monday morning, Summer Street's Mark Landy initiated coverage on the following stocks, all at Buy except for MAKO Surgical, which is rated a Neutral:
- NuVasive (Nasdaq: NUVA) - $27 price target
- Anika Therapeutics (Nasdaq: ANIK) - $9 price target
- Tornier (Nasdaq: TRNX) - $28 price target
- TranS1 (Nasdaq: TSON) - $7.50 price target
- BioMimetic Therapeutics (Nasdaq: BMTI) - $7 price target
- Alphatec (Nasdaq: ATEC) - $4.50 price target
- MAKO Surgical (Nasdaq: MAKO)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- D. Boral Capital Starts Eve Holding Inc. (EVEX) at Buy
- William Blair Starts Tandem Diabetes Care (TNDM) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
